$OREXQ News
Last published 14y ago
- 14y agoOREXQARNAFirst Diet Pill in Decade Turns Arena Into Deal Bait: Real M&ABloombergThe first medication in more than a decade to help 78 million obese Americans slim down is turning into takeover bait.
- 14y agoJWNMBIGSMS+8Arena, Darling, JPMorgan, Nuance, Renesola: U.S. Equity MoversBloombergShares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses and prices are as of 9:40 a.m. New York time.
- 14y agoOREXQARNAArena’s Weight-Loss Pill Poised for Approval in Obesity FightBloombergArena Pharmaceuticals Inc.’s weight-loss pill gained the backing of an advisory panel, putting two obesity drugs in line for U.S. approval almost two years after regulators rejected them as too risky.
- 14y agoGILDABTBMYJNJ+2Obesity Prompts Vivus Takeover Talk With 88% Windfall: Real M&ABloombergVivus Inc.’s shareholders are poised to reap an 88 percent windfall in a takeover after the company’s weight-loss drug moved one step closer to winning approval to treat America’s 78 million obese adults.
- 15y agoBIDUGILDALNYPFE+9Google, Novo Nordisk, Myriad, MPAA: Intellectual PropertyBloombergGoogle Inc. offered $900 million for the rights to about 6,000 Nortel Networks Corp. patents as the world’s biggest Internet-search company seeks to stave off lawsuits by bolstering its portfolio of intellectual property.